Latest
Cancer Drugs
& Related Newswire
7/4/2006 8:07:00 AM | Increased Awareness of Alemtuzumab-Related Infections Urged 
=(0) A new study warns doctors that a drug currently used to treat certain types of leukemia and other blood disorders may be associated with more infectious side effects than previously thought. The drug, Campath (alemtuzumab), was associated with a variety of complications such as herpes infection, toxoplasmosis, progressive multifocal leukoencep...
Read More
6/27/2006 5:31:00 PM | Milk thistle drug blocks lung cancer in mice =(0) A drug derived from the milk thistle plant has proven effective in treating lung cancer in mice. The drug, Silibinin, is already in clinical trials in humans for prostate cancer. Researchers used the pure chemical, not dietary supplements of milk thistle which are available in health food stores. The research continues..........
Read More
6/27/2006 2:14:00 PM | Sutent Offers Hope For People With Kidney Cancer =(0) Sutent, a new drug approved for treating kidney cancer, has shown encouraging results so far. The drug works by blocking blood flow to the tumor, so is effective for large as well as small cancers. Studies are still ongoing.............
Read More
6/27/2006 10:28:00 AM | Genentech Stops Avastin Pancreatic Cancer Trial As Results Fail To ... =(0) Drugmaker Genentech has stopped an experimental trial of the cancer drug Avastin for the treatment of pancreatic cancer. An independent monitoring board confirmed that the results were not going to meet the goals. Avastin is approved for treatment of several cancers including colorectal cancer, certain lung cancers and breast cancer. ...
Read More
6/27/2006 8:23:00 AM | UK's NICE Rejects Lilly's Alimta in Mesothelioma =(0) The British National Health Service's cost-control unit, "NICE", will discontinue funding a mesothelioma drug, pemetrexed (Alimta) in England and Wales. The drug's maker, Eli Lilly, contends that the drug is an effective therapy for a difficult-to-treat cancer caused almost completely by workplace exposure to asbestos. It will appeal the decis...
Read More
6/21/2006 6:40:00 PM | Cancer Drug Some Help for Scleroderma =(0) Cytoxan, a drug used to fight lung cancer, has been found to benefit patients with scleroderma as well. Scleroderma is an immune system disorder in which connective tissue is targeted, leading to scar tissue potentially throughout the body. One area of particular danger is the lungs. There is no cure but studies have found Cytoxan may slo...
Read More
6/21/2006 10:10:00 AM | Morphotek gets key FDA designation for drug =(0) The FDA has conferred "orphan drug" status for an ovarian cancer therapy under development. This has advantages for tax purposes and marketing exclusivity, meant to encourage companies to develop drugs for less common conditions. The drug, Morab-003, is a humanized monoclonal antibody..........
Read More
6/20/2006 6:36:00 AM | Health Canada Approves Unique Rheumatoid Arthritis Treatment =(0) Health Canada has approved a new medication, rituximab (Rituxan) for the treatment of rheumatoid arthritis, to be used in combination with Methotrexate for patients resistant to other therapies. Rituxan selectively binds to "B" cells which are thought to play a large role in the disease. Rituxan has already been used to treat Non-Hodgkins...
Read More
6/15/2006 12:01:00 AM | Merck CEO optimistic about outlook for Gardasil =(0) Merck is optimistic about its new cervical cancer vaccine, Gardasil. The vaccine was approved by the FDA last week. It is the first of its kind, although GlaxoSmithKline has one in development. The vaccine protects against 70% of the viruses that cause cervical cancer, and is intended for females between the ages of 9 and 26 and males between ...
Read More
6/14/2006 6:23:00 AM | Onyx drug gets 'fast track' status =(0) A drug that is currently in use for kidney cancer will received "fast track" review by the FDA for treating liver cancer patients. That means that Nexavar, made by Onyx Pharmaceuticals, may be available for this use sooner than would normally be the case. The FDA confers fast track status on drugs that are intended for life-threatening conditi...
Read More
6/14/2006 1:42:00 AM | Vaccine for lung cancer sufferers =(0) A vaccine for lung cancer is in development. It would work by causing the immune system to fight a specific protein that forms on the surface of non-small cell lung cancer tumors, a common form of lung cancer. It is hoped the vaccine would be available in the next few years. ......
Read More
6/9/2006 9:27:00 AM | US Court Dismisses Securities Action Lawsuit Against Cell ... =(0) A US District Court Judge has granted a motion to dismiss a class action lawsuit against cancer drug maker Cell Therapeutics Inc. The lawsuit alleged false statements by the company concerning trials of lung cancer drug Xyotax. Investors who bought Cell Therapeutics stock between November 2003 and March 2005 claim the company made money on sto...
Read More
6/7/2006 7:07:00 AM | Clinical Trial Confirms Novel EGFR Antibody Targets Tumors But Not ... =(0) A preliminary clinical trial of a new cancer drug has shown encouraging results. The drug is "monoclonal antibody 806" which is designed to target and attack tumor cells but not normal cells. In the first trials it seems to have done just that, for cancers of several types including mesothelioma, other lung cancers, colorectal cancer and skin canc...
Read More
6/3/2006 6:17:00 AM | Bone Drug Goes to Court =(0) A lawsuit is under way in New York requesting that Hoffman-LaRoche alter some of its claims regarding its osteoporosis drug Boniva. Proctor & Gamble, maker of rival drug Actonel, says that Boniva only reduces risk of spinal fracture while its drug and Merck's Fosamax affect other common fracture sites. Hoffman-LaRoche insists its claims a...
Read More
6/3/2006 12:15:00 AM | Drug attacks genetic roots of breast cancer =(0) A new drug is on the horizon for patients with advanced breast cancer. Tykerb is a new type of medication known as a "smart" drug, as it affects only cancer cells, not healthy ones. It is intended for women who aren't responding to Herceptin. Tykerb can be taken in pill form, and has fewer side effects than Herceptin as well. Th...
Read More
6/2/2006 8:28:00 PM | Bowel cancer drugs denied NHS funding =(0) Britain's National Health Service will not currently fund two new bowel cancer drugs, bevacizumab (Avastin) and cetuximab (Erbitux). Cancer advocacy groups and charities oppose this decision, saying it is financially motivated and that the drugs prolong the lives of patients with advanced cancers. Those behind the decision claim that the benef...
Read More
5/26/2006 1:50:00 PM | Suit to benefit Clinic =(0) The State of Wisconsin has received a settlement of nearly $800,000 as the result of a lawsuit against TAP Pharmaceutical Products Inc, the makers of the anti-cancer drug Lupron. TAP was found to have inflated prices for the drug, thus defrauding Medicare and Medicaid, other insurers and patients who pay portions of the cost. Some crimina...
Read More
5/25/2006 5:11:00 PM | Parexel Drug Trial Had Shortfalls, UK Probe Finds =(0) The UK Health Regulator has issued a report on the drug-testing fiasco that occurred in London this year. Six men suffered multiple organ failure and became extremely ill after taking an experimental drug. One remains in hospital, recovering, three months after taking the drug. The report says that there was no errors in the manufacture ...
Read More
5/25/2006 3:13:00 AM | Androgen Deprivation Therapy Associated With A Significant Risk Of ... =(0) Men treated for prostate cancer with androgen deprivation therapy run an increased risk of developing diabetes, and the risk increases with obesity, according to a recent report. This type of therapy, also known as "hormonal" therapy, can be the result of surgery or of prescribed medication in the class of LHRH agonists such as Lupron. Do...
Read More
5/19/2006 12:33:00 PM | Panel: Cervical cancer vaccine passes the test =(0) An FDA advisory committee recommends approval of Merck's new cervical cancer vaccine, Gardasil, with a final decision to be made in June. The vaccine is expected to be effective against the forms of Human Papilloma Virus (HPV) that cause 70% of cases of cancer of the cervix, and 90% of cases of genital warts. The vaccine appears to be saf...
Read More
Drugs & Side Effects News 1